Copyright Reports & Markets. All rights reserved.

Global Long Acting Insulins Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Long Acting Insulins Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Insulin Glargine
      • 1.4.3 Insulin Determir
      • 1.4.4 Insulin Degludec
      • 1.4.5 Long Acting Animal Insulin
    • 1.5 Market by Application
      • 1.5.1 Global Long Acting Insulins Market Share by Application (2014-2025)
      • 1.5.2 Home Use
      • 1.5.3 Medical Institutions
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Long Acting Insulins Market Size
    • 2.2 Long Acting Insulins Growth Trends by Regions
      • 2.2.1 Long Acting Insulins Market Size by Regions (2014-2025)
      • 2.2.2 Long Acting Insulins Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Long Acting Insulins Market Size by Manufacturers
      • 3.1.1 Global Long Acting Insulins Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Long Acting Insulins Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)
    • 3.2 Long Acting Insulins Key Players Head office and Area Served
    • 3.3 Key Players Long Acting Insulins Product/Solution/Service
    • 3.4 Date of Enter into Long Acting Insulins Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Long Acting Insulins Market Size by Type (2014-2019)
    • 4.2 Global Long Acting Insulins Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Long Acting Insulins Market Size (2014-2019)
    • 5.2 Long Acting Insulins Key Players in United States
    • 5.3 United States Long Acting Insulins Market Size by Type
    • 5.4 United States Long Acting Insulins Market Size by Application

    6 Europe

    • 6.1 Europe Long Acting Insulins Market Size (2014-2019)
    • 6.2 Long Acting Insulins Key Players in Europe
    • 6.3 Europe Long Acting Insulins Market Size by Type
    • 6.4 Europe Long Acting Insulins Market Size by Application

    7 China

    • 7.1 China Long Acting Insulins Market Size (2014-2019)
    • 7.2 Long Acting Insulins Key Players in China
    • 7.3 China Long Acting Insulins Market Size by Type
    • 7.4 China Long Acting Insulins Market Size by Application

    8 Japan

    • 8.1 Japan Long Acting Insulins Market Size (2014-2019)
    • 8.2 Long Acting Insulins Key Players in Japan
    • 8.3 Japan Long Acting Insulins Market Size by Type
    • 8.4 Japan Long Acting Insulins Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Long Acting Insulins Market Size (2014-2019)
    • 9.2 Long Acting Insulins Key Players in Southeast Asia
    • 9.3 Southeast Asia Long Acting Insulins Market Size by Type
    • 9.4 Southeast Asia Long Acting Insulins Market Size by Application

    10 India

    • 10.1 India Long Acting Insulins Market Size (2014-2019)
    • 10.2 Long Acting Insulins Key Players in India
    • 10.3 India Long Acting Insulins Market Size by Type
    • 10.4 India Long Acting Insulins Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Long Acting Insulins Market Size (2014-2019)
    • 11.2 Long Acting Insulins Key Players in Central & South America
    • 11.3 Central & South America Long Acting Insulins Market Size by Type
    • 11.4 Central & South America Long Acting Insulins Market Size by Application

    12 International Players Profiles

    • 12.1 Novo Nordisk
      • 12.1.1 Novo Nordisk Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Long Acting Insulins Introduction
      • 12.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2014-2019)
      • 12.1.5 Novo Nordisk Recent Development
    • 12.2 Sanofi
      • 12.2.1 Sanofi Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Long Acting Insulins Introduction
      • 12.2.4 Sanofi Revenue in Long Acting Insulins Business (2014-2019)
      • 12.2.5 Sanofi Recent Development
    • 12.3 Wockhardt UK
      • 12.3.1 Wockhardt UK Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Long Acting Insulins Introduction
      • 12.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2014-2019)
      • 12.3.5 Wockhardt UK Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
      In 2018, the global Long Acting Insulins market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Long Acting Insulins status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Long Acting Insulins development in United States, Europe and China.

      The key players covered in this study
      Novo Nordisk
      Sanofi
      Wockhardt UK
      ...

      Market segment by Type, the product can be split into
      Insulin Glargine
      Insulin Determir
      Insulin Degludec
      Long Acting Animal Insulin

      Market segment by Application, split into
      Home Use
      Medical Institutions
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Long Acting Insulins status, future forecast, growth opportunity, key market and key players.
      To present the Long Acting Insulins development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Long Acting Insulins are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now